NECO2: Study of the Influence of Intraperitoneal Insufflation of CO2 by Laparoscopy on the Short-term Evolution of Premature Infants With Ulcerative Necrotizing Enterocolitis

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05882448
Collaborator
(none)
54
2
2
24
27
1.1

Study Details

Study Description

Brief Summary

Ulcerative-necrotizing enterocolitis (ECUN) is an infectious and inflammatory disease of the digestive tract, which can lead to intestinal necrosis or perforation.

This severe pathology of the newborn , often premature, requires urgent medical and surgical treatment in 25 to 50% of cases. The morbidity is high, both digestive and neurological. ECUN can lead to complications at short-term (death, intestinal stenosis) and at long-term (neuro-cognitive disorders). The challenge of preserving the neurological development is a major issue. It involves control of inflammation. This inflammation causes neurological lesions and is responsible for a disorder of the long-term neurocognitive development.

At Robert-Debré and Trousseau, the management of newborns with ECUN is focused on the control of this inflammation. A laparoscopy is performed first. The carbon dioxide (CO2) insufflated into the abdomen during a laparoscopy is thought to have an anti-inflammatory effect according to several experimental and clinical studies. A preliminary retrospective study at Robert-Debré showed a decrease in postoperative inflammation (decrease in C reactive protein at Day2 and Day 7 post-op) as well as a decrease in morbimortality (decrease in the rate of stoma and reoperation) in children who had a laparoscopic first operation compared to those who had a laparotomy alone. However, in many hospitals, laparotomy alone is currently the only surgical option.

This preliminary study may demonstrate that laparoscopy decreases early morbidity and mortality in children with ECUN through reduced inflammation, as reflected by postoperative C reactive protein.

Condition or Disease Intervention/Treatment Phase
  • Procedure: laparotomy
  • Procedure: Laparoscopy
N/A

Detailed Description

NECO2 is a pilot trial, evaluating the intermediate effectiveness to short/medium term of laparoscopy on the inflammatory reaction of premature newborns with complicated ECUN, requiring surgical treatment.

This is a multicenter randomized controlled trial in single blind, in two parallel arms, in ratio 1:1, of superiority.

This trial compares laparoscopy plus laparotomy versus laparotomy alone.

Children will be randomized into 2 groups:
  • Laparoscopy + laparotomy group

  • Laparotomy group

The main objective is to evaluate the inflammatory response Day 2 postoperative in preterm infants with ECUN who have undergone surgery.

The main criterion is the evolution of the blood C reactive protein level between Day 0 and Day 2 postoperatively.

The secondary objectives are:To evaluate in premature babies with ECUN who have had a surgical intervention (laparoscopy + laparotomy or laparotomy alone):

A.The postoperative biological inflammatory response at Day 7 B.Post-operative biological inflammatory response from Day 0 to Day 7 C.Post-operative mortality D.Post-operative bowel morbidity E.Post-operative re-intervention rate F.Length of hospital stay G.Post-operative neurological morbidity, medium term (corrected term 41 SA)

  • To evaluate the tolerance of laparoscopy :

H.Intraoperative cardiorespiratory I.Loco-regional lesions linked to the insertion of the trocar

Secondary endpoints:
  1. C reactive protein blood level at Day 7 B. Blood levels of Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha at Day 1, Day 2, Day 4, Day 7 C. Postoperative death from any cause D. Stoma rate, duration of parenteral nutrition, duration of hemodynamic support, duration of invasive ventilation (High frequency oscillatory ventilation/Synchronized Intermittent Mandatory Ventilation), Post-ECUN intestinal stenosis rate E. Re-intervention (laparotomy) and cause (post-ECUN stenosis, stoma closure) F. Length of hospital stay until return home G. Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at the corrected term of 41 weeks of amenorrhea, H. Oxygen saturation (SaO2), hypercapnia (pCO2) blood pressure (BP), cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively I. Intraoperative clinical monitoring: exploration of adjacent organs. Post-operative clinical monitoring: digestive signs monitoring of wounds until discharge.

Group 1: laparotomy only Group 2: laparotomy and laparoscopy

Study Design

Study Type:
Interventional
Anticipated Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
parallel assignmentparallel assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
At the end of the operation, two dressings will be placed on the child's abdomen to ensure the blindness of the health professionals performing the postoperative care and the parents.
Primary Purpose:
Treatment
Official Title:
Study of the Influence of Intraperitoneal Insufflation of Carbon Dioxide (CO2) by Laparoscopy on the Short-term Evolution of Premature Infants With Ulcerative Necrotizing Enterocolitis
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Laparotomy

Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion

Procedure: laparotomy
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion

Experimental: Laparotomy and laparoscopy

Exploratory and therapeutic laparotomy if necessary preceded by laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes.

Procedure: laparotomy
Exploratory and therapeutic laparotomy if necessary, in case of necrotic intestine requiring resection with anastomosis or stoma-type bowel diversion

Procedure: Laparoscopy
laparoscopy with insufflation of CO2 (placement of a 3mm trocar in the left hypochondrium and insufflation of a pneumoperitoneum (carbon dioxide, pressure: 6 mmHg, flow rate: 1.5 Liter/minute) for a duration of at least 5 minutes.

Outcome Measures

Primary Outcome Measures

  1. C reactive protein blood level [between Day 0 and Day 2 post surgery]

    C reactive protein blood level

Secondary Outcome Measures

  1. Postoperative biological inflammatory reaction [Day 7 post surgery]

    C reactive protein blood level

  2. Specific post-operative biological inflammatory reaction [Day1, day 2, day 4 and day 7 post surgery]

    Procalcitonin, Interleukin 6 and Tumor Necrosis Factor-alpha blood level

  3. Postoperative mortality [up to 3 months]

    Death due to any postoperative cause

  4. Postoperative intestinal morbidity: stoma rate [up to 3 months]

    Stoma rate

  5. Postoperative intestinal morbidity: Duration of parenteral nutrition [up to 3 months]

    Duration of parenteral nutrition

  6. Postoperative intestinal morbidity: Duration of hemodynamic support [up to 3 months]

    Duration of hemodynamic support

  7. Postoperative intestinal morbidity: Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation) [up to 3 months]

    Duration of invasive ventilation (HFO: High frequency oscillatory ventilation/VACI: Synchronized Intermittent Mandatory Ventilation)

  8. Postoperative intestinal morbidity: Rate of intestinal stenosis post-ECUN [up to 3 months]

    Rate of intestinal stenosis post-ECUN

  9. Postoperative reoperation rate [up to 3 months]

    Reoperation (laparotomy) and cause (post ECUN stenosis, stoma closure)

  10. Length of hospitalization [up to 3 months]

    Duration of hospitalization until return home

  11. Medium-term postoperative neurological morbidity [up to 3 months]

    Early postoperative neurological lesions observed on transfontanellar ultrasound and MRI at term corrected for 41 weeks of amenorrhea

  12. Oxygen saturation (SaO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory)) [During Surgery]

    Oxygen saturation (SaO2)

  13. Hypercapnia (pCO2) (Tolerance of laparoscopy (Intraoperative cardio-respiratory)) [During Surgery]

    hypercapnia (pCO2)

  14. Blood pressure (BP) (Tolerance of laparoscopy (Intraoperative cardio-respiratory)) [During Surgery]

    blood pressure (systolic and diastolic)

  15. Cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) (Tolerance of laparoscopy (Intraoperative cardio-respiratory)) [During Surgery]

    cerebral oxygenation (Near InfraRed Spectroscopy (NIRS)) intraoperatively

  16. Presence of loco-regional lesions related to the insertion of the trocar (Tolerance of laparoscopy) [up to 3 months]

    Presence of loco-regional lesions related to the insertion of the trocar

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Premature newborn (term of birth: <37 weeks of amenorrhea)

  • Diagnosis of ECUN by the surgeon (distension abdominal +/- rectal bleeding +/- green gastric residue, increased biological inflammatory syndrome, + pneumatosis on abdominal radiography)

  • Hospitalized and complicated ECUN: presenting either a pneumoperitoneum on abdominal X-ray or a absence of clinical and biological improvement after 48 hours of maximum well-conducted medical treatment (IV antibiotic therapy and digestive rest).

  • Hospitalized in the 2 participating centers

  • Of which the 2 holders of parental authority have been informed and have signed the consent form

  • Having social security coverage (social security or CMU)

Exclusion Criteria:
  • Instability contraindicating movement to the operating room or contraindicating CO2 insufflation

  • Diagnosis of isolated perforation of the small intestine (radiography:

pneumoperitoneum without pneumatosis)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Armand Trousseau Service de Chirurgie Pédiatrique et Néonatale Paris France 75012
2 Hôpital Robert Debré Service de Chirurgie Pédiatrique Paris France

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT05882448
Other Study ID Numbers:
  • APHP221170
First Posted:
May 31, 2023
Last Update Posted:
May 31, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 31, 2023